HEADER TRANSFERASE 30-MAY-23 8P76 TITLE CRYO-EM STRUCTURE OF CAK IN COMPLEX WITH INHIBITOR ICEC0914 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CDK-ACTIVATING KINASE ASSEMBLY FACTOR MAT1; COMPND 3 CHAIN: H; COMPND 4 SYNONYM: CDK7/CYCLIN-H ASSEMBLY FACTOR,CYCLIN-G1-INTERACTING PROTEIN, COMPND 5 MENAGE A TROIS,RING FINGER PROTEIN 66,RING FINGER PROTEIN MAT1,P35, COMPND 6 P36; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CYCLIN-H; COMPND 10 CHAIN: I; COMPND 11 SYNONYM: MO15-ASSOCIATED PROTEIN,P34,P37; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: CYCLIN-DEPENDENT KINASE 7; COMPND 15 CHAIN: J; COMPND 16 SYNONYM: 39 KDA PROTEIN KINASE,P39 MO15,CDK-ACTIVATING KINASE 1,CELL COMPND 17 DIVISION PROTEIN KINASE 7,SERINE/THREONINE-PROTEIN KINASE 1,TFIIH COMPND 18 BASAL TRANSCRIPTION FACTOR COMPLEX KINASE SUBUNIT; COMPND 19 EC: 2.7.11.22,2.7.11.23; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MNAT1, CAP35, MAT1, RNF66; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCNH; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: CDK7, CAK, CAK1, CDKN7, MO15, STK1; SOURCE 20 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS KINASE, INHIBITOR, TRANSCRIPTION, CELL CYCLE, TRANSFERASE EXPDTA ELECTRON MICROSCOPY AUTHOR V.I.CUSHING,A.F.KOH,J.FENG,K.JURGAITYTE,A.K.BAHL,S.ALI,A.KOTECHA, AUTHOR 2 B.J.GREBER REVDAT 2 27-MAR-24 8P76 1 JRNL REVDAT 1 20-MAR-24 8P76 0 JRNL AUTH V.I.CUSHING,A.F.KOH,J.FENG,K.JURGAITYTE,A.BONDKE, JRNL AUTH 2 S.H.B.KROLL,M.BARBAZANGES,B.SCHEIPER,A.K.BAHL,A.G.M.BARRETT, JRNL AUTH 3 S.ALI,A.KOTECHA,B.J.GREBER JRNL TITL HIGH-RESOLUTION CRYO-EM OF THE HUMAN CDK-ACTIVATING KINASE JRNL TITL 2 FOR STRUCTURE-BASED DRUG DESIGN. JRNL REF NAT COMMUN V. 15 2265 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38480681 JRNL DOI 10.1038/S41467-024-46375-9 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, EPU, RELION, CRYOSPARC, UCSF REMARK 3 CHIMERAX, PHENIX, RELION, RELION, REMARK 3 RELION, RELION REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 8ORM REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.000 REMARK 3 NUMBER OF PARTICLES : 237743 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8P76 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1292130009. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CDK-ACTIVATING KINASE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.40 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.90 REMARK 245 SAMPLE DETAILS : CAK IN COMPLEX WITH NON REMARK 245 -COVALENT INHIBITOR ICEC0914 REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 5202 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : TFS FALCON 4I (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 400.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 7000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : 245614 REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER H 217 REMARK 465 ASN H 218 REMARK 465 ALA H 219 REMARK 465 PRO H 220 REMARK 465 VAL H 221 REMARK 465 THR H 222 REMARK 465 PHE H 223 REMARK 465 SER H 224 REMARK 465 THR H 225 REMARK 465 GLY H 226 REMARK 465 ILE H 227 REMARK 465 LYS H 228 REMARK 465 MET H 229 REMARK 465 GLY H 230 REMARK 465 GLN H 231 REMARK 465 HIS H 232 REMARK 465 ILE H 233 REMARK 465 SER H 234 REMARK 465 LEU H 235 REMARK 465 ALA H 236 REMARK 465 PRO H 237 REMARK 465 ILE H 238 REMARK 465 HIS H 239 REMARK 465 LYS H 240 REMARK 465 LEU H 241 REMARK 465 GLU H 242 REMARK 465 GLU H 243 REMARK 465 SER H 309 REMARK 465 LYS I 39 REMARK 465 VAL I 40 REMARK 465 LEU I 41 REMARK 465 PRO I 42 REMARK 465 ASN I 43 REMARK 465 LEU I 285 REMARK 465 ALA I 286 REMARK 465 LEU I 287 REMARK 465 ASN I 288 REMARK 465 VAL I 289 REMARK 465 ILE I 290 REMARK 465 THR I 291 REMARK 465 LYS I 292 REMARK 465 LYS I 293 REMARK 465 ARG I 294 REMARK 465 LYS I 295 REMARK 465 GLY I 296 REMARK 465 TYR I 297 REMARK 465 GLU I 298 REMARK 465 ASP I 299 REMARK 465 ASP I 300 REMARK 465 ASP I 301 REMARK 465 TYR I 302 REMARK 465 VAL I 303 REMARK 465 SER I 304 REMARK 465 LYS I 305 REMARK 465 LYS I 306 REMARK 465 SER I 307 REMARK 465 LYS I 308 REMARK 465 HIS I 309 REMARK 465 GLU I 310 REMARK 465 GLU I 311 REMARK 465 GLU I 312 REMARK 465 GLU I 313 REMARK 465 TRP I 314 REMARK 465 THR I 315 REMARK 465 ASP I 316 REMARK 465 ASP I 317 REMARK 465 ASP I 318 REMARK 465 LEU I 319 REMARK 465 VAL I 320 REMARK 465 GLU I 321 REMARK 465 SER I 322 REMARK 465 LEU I 323 REMARK 465 SER J -2 REMARK 465 ASN J -1 REMARK 465 ALA J 0 REMARK 465 MET J 1 REMARK 465 ALA J 2 REMARK 465 LEU J 3 REMARK 465 ASP J 4 REMARK 465 VAL J 5 REMARK 465 LYS J 6 REMARK 465 SER J 7 REMARK 465 ARG J 8 REMARK 465 ALA J 9 REMARK 465 ASP J 31 REMARK 465 LYS J 32 REMARK 465 ASN J 33 REMARK 465 THR J 34 REMARK 465 ASN J 35 REMARK 465 GLN J 36 REMARK 465 ILE J 43 REMARK 465 LYS J 44 REMARK 465 LEU J 45 REMARK 465 GLY J 46 REMARK 465 HIS J 47 REMARK 465 ARG J 48 REMARK 465 SER J 49 REMARK 465 GLU J 50 REMARK 465 ALA J 51 REMARK 465 ASN J 311 REMARK 465 CYS J 312 REMARK 465 PRO J 313 REMARK 465 VAL J 314 REMARK 465 GLU J 315 REMARK 465 THR J 316 REMARK 465 LEU J 317 REMARK 465 LYS J 318 REMARK 465 GLU J 319 REMARK 465 GLN J 320 REMARK 465 SER J 321 REMARK 465 ASN J 322 REMARK 465 PRO J 323 REMARK 465 ALA J 324 REMARK 465 LEU J 325 REMARK 465 ALA J 326 REMARK 465 ILE J 327 REMARK 465 LYS J 328 REMARK 465 ARG J 329 REMARK 465 LYS J 330 REMARK 465 ARG J 331 REMARK 465 THR J 332 REMARK 465 GLU J 333 REMARK 465 ALA J 334 REMARK 465 LEU J 335 REMARK 465 GLU J 336 REMARK 465 GLN J 337 REMARK 465 GLY J 338 REMARK 465 GLY J 339 REMARK 465 LEU J 340 REMARK 465 PRO J 341 REMARK 465 LYS J 342 REMARK 465 LYS J 343 REMARK 465 LEU J 344 REMARK 465 ILE J 345 REMARK 465 PHE J 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU I 234 -60.58 -91.82 REMARK 500 MET I 237 16.20 56.32 REMARK 500 LYS J 84 -132.97 58.76 REMARK 500 ASP J 137 37.20 -141.00 REMARK 500 ASN J 166 54.81 -92.86 REMARK 500 VAL J 174 136.44 69.09 REMARK 500 TRP J 237 88.07 -159.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-17129 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF CAK-THZ1 REMARK 900 RELATED ID: EMD-17519 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF CAK IN COMPLEX WITH INHIBITOR ICEC0914 REMARK 900 RELATED ID: 8ORM RELATED DB: PDB REMARK 900 CRYO-EM STRUCTURE OF CAK-THZ1 DBREF 8P76 H 220 309 UNP P51948 MAT1_HUMAN 220 309 DBREF 8P76 I 1 323 UNP P51946 CCNH_HUMAN 1 323 DBREF 8P76 J 1 346 UNP P50613 CDK7_HUMAN 1 346 SEQADV 8P76 SER H 217 UNP P51948 EXPRESSION TAG SEQADV 8P76 ASN H 218 UNP P51948 EXPRESSION TAG SEQADV 8P76 ALA H 219 UNP P51948 EXPRESSION TAG SEQADV 8P76 ACE I 0 UNP P51946 ACETYLATION SEQADV 8P76 SER J -2 UNP P50613 EXPRESSION TAG SEQADV 8P76 ASN J -1 UNP P50613 EXPRESSION TAG SEQADV 8P76 ALA J 0 UNP P50613 EXPRESSION TAG SEQRES 1 H 93 SER ASN ALA PRO VAL THR PHE SER THR GLY ILE LYS MET SEQRES 2 H 93 GLY GLN HIS ILE SER LEU ALA PRO ILE HIS LYS LEU GLU SEQRES 3 H 93 GLU ALA LEU TYR GLU TYR GLN PRO LEU GLN ILE GLU THR SEQRES 4 H 93 TYR GLY PRO HIS VAL PRO GLU LEU GLU MET LEU GLY ARG SEQRES 5 H 93 LEU GLY TYR LEU ASN HIS VAL ARG ALA ALA SER PRO GLN SEQRES 6 H 93 ASP LEU ALA GLY GLY TYR THR SER SER LEU ALA CYS HIS SEQRES 7 H 93 ARG ALA LEU GLN ASP ALA PHE SER GLY LEU PHE TRP GLN SEQRES 8 H 93 PRO SER SEQRES 1 I 324 ACE MET TYR HIS ASN SER SER GLN LYS ARG HIS TRP THR SEQRES 2 I 324 PHE SER SER GLU GLU GLN LEU ALA ARG LEU ARG ALA ASP SEQRES 3 I 324 ALA ASN ARG LYS PHE ARG CYS LYS ALA VAL ALA ASN GLY SEQRES 4 I 324 LYS VAL LEU PRO ASN ASP PRO VAL PHE LEU GLU PRO HIS SEQRES 5 I 324 GLU GLU MET THR LEU CYS LYS TYR TYR GLU LYS ARG LEU SEQRES 6 I 324 LEU GLU PHE CYS SER VAL PHE LYS PRO ALA MET PRO ARG SEQRES 7 I 324 SER VAL VAL GLY THR ALA CYS MET TYR PHE LYS ARG PHE SEQRES 8 I 324 TYR LEU ASN ASN SER VAL MET GLU TYR HIS PRO ARG ILE SEQRES 9 I 324 ILE MET LEU THR CYS ALA PHE LEU ALA CYS LYS VAL ASP SEQRES 10 I 324 GLU PHE ASN VAL SER SER PRO GLN PHE VAL GLY ASN LEU SEQRES 11 I 324 ARG GLU SER PRO LEU GLY GLN GLU LYS ALA LEU GLU GLN SEQRES 12 I 324 ILE LEU GLU TYR GLU LEU LEU LEU ILE GLN GLN LEU ASN SEQRES 13 I 324 PHE HIS LEU ILE VAL HIS ASN PRO TYR ARG PRO PHE GLU SEQRES 14 I 324 GLY PHE LEU ILE ASP LEU LYS THR ARG TYR PRO ILE LEU SEQRES 15 I 324 GLU ASN PRO GLU ILE LEU ARG LYS THR ALA ASP ASP PHE SEQRES 16 I 324 LEU ASN ARG ILE ALA LEU THR ASP ALA TYR LEU LEU TYR SEQRES 17 I 324 THR PRO SER GLN ILE ALA LEU THR ALA ILE LEU SER SER SEQRES 18 I 324 ALA SER ARG ALA GLY ILE THR MET GLU SER TYR LEU SER SEQRES 19 I 324 GLU SER LEU MET LEU LYS GLU ASN ARG THR CYS LEU SER SEQRES 20 I 324 GLN LEU LEU ASP ILE MET LYS SER MET ARG ASN LEU VAL SEQRES 21 I 324 LYS LYS TYR GLU PRO PRO ARG SER GLU GLU VAL ALA VAL SEQRES 22 I 324 LEU LYS GLN LYS LEU GLU ARG CYS HIS SER ALA GLU LEU SEQRES 23 I 324 ALA LEU ASN VAL ILE THR LYS LYS ARG LYS GLY TYR GLU SEQRES 24 I 324 ASP ASP ASP TYR VAL SER LYS LYS SER LYS HIS GLU GLU SEQRES 25 I 324 GLU GLU TRP THR ASP ASP ASP LEU VAL GLU SER LEU SEQRES 1 J 349 SER ASN ALA MET ALA LEU ASP VAL LYS SER ARG ALA LYS SEQRES 2 J 349 ARG TYR GLU LYS LEU ASP PHE LEU GLY GLU GLY GLN PHE SEQRES 3 J 349 ALA THR VAL TYR LYS ALA ARG ASP LYS ASN THR ASN GLN SEQRES 4 J 349 ILE VAL ALA ILE LYS LYS ILE LYS LEU GLY HIS ARG SER SEQRES 5 J 349 GLU ALA LYS ASP GLY ILE ASN ARG THR ALA LEU ARG GLU SEQRES 6 J 349 ILE LYS LEU LEU GLN GLU LEU SER HIS PRO ASN ILE ILE SEQRES 7 J 349 GLY LEU LEU ASP ALA PHE GLY HIS LYS SER ASN ILE SER SEQRES 8 J 349 LEU VAL PHE ASP PHE MET GLU THR ASP LEU GLU VAL ILE SEQRES 9 J 349 ILE LYS ASP ASN SER LEU VAL LEU THR PRO SER HIS ILE SEQRES 10 J 349 LYS ALA TYR MET LEU MET THR LEU GLN GLY LEU GLU TYR SEQRES 11 J 349 LEU HIS GLN HIS TRP ILE LEU HIS ARG ASP LEU LYS PRO SEQRES 12 J 349 ASN ASN LEU LEU LEU ASP GLU ASN GLY VAL LEU LYS LEU SEQRES 13 J 349 ALA ASP PHE GLY LEU ALA LYS SER PHE GLY SER PRO ASN SEQRES 14 J 349 ARG ALA TYR THR HIS GLN VAL VAL THR ARG TRP TYR ARG SEQRES 15 J 349 ALA PRO GLU LEU LEU PHE GLY ALA ARG MET TYR GLY VAL SEQRES 16 J 349 GLY VAL ASP MET TRP ALA VAL GLY CYS ILE LEU ALA GLU SEQRES 17 J 349 LEU LEU LEU ARG VAL PRO PHE LEU PRO GLY ASP SER ASP SEQRES 18 J 349 LEU ASP GLN LEU THR ARG ILE PHE GLU THR LEU GLY THR SEQRES 19 J 349 PRO THR GLU GLU GLN TRP PRO ASP MET CYS SER LEU PRO SEQRES 20 J 349 ASP TYR VAL THR PHE LYS SER PHE PRO GLY ILE PRO LEU SEQRES 21 J 349 HIS HIS ILE PHE SER ALA ALA GLY ASP ASP LEU LEU ASP SEQRES 22 J 349 LEU ILE GLN GLY LEU PHE LEU PHE ASN PRO CYS ALA ARG SEQRES 23 J 349 ILE THR ALA THR GLN ALA LEU LYS MET LYS TYR PHE SER SEQRES 24 J 349 ASN ARG PRO GLY PRO THR PRO GLY CYS GLN LEU PRO ARG SEQRES 25 J 349 PRO ASN CYS PRO VAL GLU THR LEU LYS GLU GLN SER ASN SEQRES 26 J 349 PRO ALA LEU ALA ILE LYS ARG LYS ARG THR GLU ALA LEU SEQRES 27 J 349 GLU GLN GLY GLY LEU PRO LYS LYS LEU ILE PHE HET ACE I 0 3 HET X1W J 401 34 HETNAM ACE ACETYL GROUP HETNAM X1W N5-[(3S,4R)-4-PHENYLMETHOXYPYRROLIDIN-3-YL]-N7- HETNAM 2 X1W (PHENYLMETHYL)-3-PROPAN-2-YL-PYRAZOLO[1,5- HETNAM 3 X1W A]PYRIMIDINE-5,7-DIAMINE FORMUL 2 ACE C2 H4 O FORMUL 4 X1W C27 H32 N6 O FORMUL 5 HOH *151(H2 O) HELIX 1 AA1 GLU H 262 VAL H 275 5 14 HELIX 2 AA2 SER H 279 GLY H 286 1 8 HELIX 3 AA3 THR H 288 SER H 302 1 15 HELIX 4 AA4 MET I 1 ASN I 4 5 4 HELIX 5 AA5 SER I 5 TRP I 11 1 7 HELIX 6 AA6 SER I 15 ALA I 36 1 22 HELIX 7 AA7 GLU I 49 VAL I 70 1 22 HELIX 8 AA8 PRO I 76 ASN I 93 1 18 HELIX 9 AA9 HIS I 100 GLU I 117 1 18 HELIX 10 AB1 SER I 121 GLY I 127 1 7 HELIX 11 AB2 SER I 132 LEU I 154 1 23 HELIX 12 AB3 PRO I 163 TYR I 178 1 16 HELIX 13 AB4 ASN I 183 LEU I 187 5 5 HELIX 14 AB5 ARG I 188 THR I 201 1 14 HELIX 15 AB6 ASP I 202 LEU I 206 5 5 HELIX 16 AB7 THR I 208 ALA I 224 1 17 HELIX 17 AB8 MET I 228 GLU I 234 1 7 HELIX 18 AB9 MET I 237 GLU I 240 5 4 HELIX 19 AC1 ASN I 241 LYS I 261 1 21 HELIX 20 AC2 ARG I 266 ALA I 283 1 18 HELIX 21 AC3 ASN J 56 GLN J 67 1 12 HELIX 22 AC4 LEU J 98 ASP J 104 1 7 HELIX 23 AC5 THR J 110 HIS J 131 1 22 HELIX 24 AC6 THR J 175 ARG J 179 5 5 HELIX 25 AC7 ALA J 180 PHE J 185 1 6 HELIX 26 AC8 VAL J 192 ARG J 209 1 18 HELIX 27 AC9 SER J 217 GLY J 230 1 14 HELIX 28 AD1 ASP J 239 LEU J 243 5 5 HELIX 29 AD2 PRO J 256 PHE J 261 1 6 HELIX 30 AD3 GLY J 265 PHE J 276 1 12 HELIX 31 AD4 THR J 285 MET J 292 1 8 HELIX 32 AD5 MET J 292 ASN J 297 1 6 HELIX 33 AD6 PRO J 303 LEU J 307 5 5 SHEET 1 AA1 5 GLU J 13 GLU J 20 0 SHEET 2 AA1 5 THR J 25 ARG J 30 -1 O VAL J 26 N LEU J 18 SHEET 3 AA1 5 VAL J 38 LYS J 42 -1 O VAL J 38 N ALA J 29 SHEET 4 AA1 5 SER J 88 ASP J 92 -1 O LEU J 89 N LYS J 41 SHEET 5 AA1 5 LEU J 77 PHE J 81 -1 N PHE J 81 O SER J 88 SHEET 1 AA2 3 THR J 96 ASP J 97 0 SHEET 2 AA2 3 LEU J 143 LEU J 145 -1 O LEU J 145 N THR J 96 SHEET 3 AA2 3 LEU J 151 LEU J 153 -1 O LYS J 152 N LEU J 144 SHEET 1 AA3 2 ILE J 133 LEU J 134 0 SHEET 2 AA3 2 LYS J 160 SER J 161 -1 O LYS J 160 N LEU J 134 LINK C ACE I 0 N MET I 1 1555 1555 1.33 CISPEP 1 LYS I 72 PRO I 73 0 1.77 CISPEP 2 ARG J 298 PRO J 299 0 -6.36 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000